The Centers for Disease Control and Prevention is assisting in a on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures. Reports of Paraburkholderia fungorum detected in blood cultures from patients across multiple health care facilities prompted the investigation, and the CDC said it was aware of 40 confirmed cases of the bacteria in four states and two other countries as of May 8. Tests found at least two contaminated products under the MediChoice and ClearImage brands that are manufactured by NEXT Medical Products Company. The CDC provided a series of recommendations for health care providers to ensure patient safety and prevent potential outbreaks.

Related News Articles

Headline
Shelley Hart, R.N., clinical nurse specialist at Froedtert Menomonee Falls Hospital, explores the hospital's inspiring journey toward delivering exceptional…
Headline
Carolyn Bogard, DNP, R.N., director of care coordination and palliative care at El Camino Health, talks about her system’s use of data to harness the passion…
Headline
Gilchrist in Baltimore and Bristol Hospice — Hawaii are winners of the AHA 2025 Circle of Life Award for their efforts in palliative and end-of-life care. The…
Headline
Older adults may be in circumstances that exacerbate challenges to accessing behavioral health care and have complex needs that can complicate behavioral…
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…
Headline
The Centers for Medicare & Medicaid Services Feb. 14 announced it ceased implementation of the Hospice Special Focus Program so the agency can further…